CIK 0001885827 · Non-accelerated filer<br>Emerging growth company
Virax Biolabs Group Ltd
Sign in to watch- Ticker
- VRAX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Mar 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 44 020 7788 7414
- Business address
- BIOCITY GLASGOW, BO'NESS ROAD, NEWHOUSE, LANARKSHIRE, United Kingdom, ML1 5UH
- Former names
- Virax Biolabs (Cayman) Ltd
- EFFECT Other Notice of Effectiveness
- F-3/A Offering F-3/A
- F-3 Offering F-3
- EFFECT Other Notice of Effectiveness
- F-3 Offering F-3
- D Other Notice of Sales of Unregistered Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- NT 20-F Other Notification of Inability to Timely File
- EFFECT Other Notice of Effectiveness
- F-3 Offering F-3
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- NT 20-F Other Notification of Inability to Timely File
- CERT Other Certification
- FWP Offering Free Writing Prospectus
- EFFECT Other Notice of Effectiveness
- FWP Offering Free Writing Prospectus
- 8-A12B Other Registration of Securities
Page 1 of 2 · 23 filings